You turn to us for voices you won't hear anywhere else.

Sign up for Democracy Now!'s Daily Digest to get our latest headlines and stories delivered to your inbox every day.

FDA Approves Remdesivir for COVID-19 Despite WHO Study Showing No Benefit

HeadlineOct 23, 2020

The Food and Drug Administration has approved remdesivir as the first COVID-19 treatment in the United States. Some studies have shown the antiviral drug may reduce the number of days COVID-19 patients are hospitalized, though a large World Health Organization study published last week found remdesivir fails to prevent deaths among COVID-19 patients.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top